Document is current
Any future updates will be listed below
-
Authors
Fang, Zhenhao https://orcid.org/0000-0002-1246-3665
Monteiro, Valter S.
Oh, Changin
Janabi, Kawthar Al
Romero, Luciano
Ahsan, Nabihah
Yang, Luojia
Peng, Lei
DiMaio, Daniel https://orcid.org/0000-0002-2060-5977
Lucas, Carolina
Chen, Sidi https://orcid.org/0000-0002-3819-5005
-
Funding
Funding for this research was provided by:
Cancer Research Institute (CRI4964)
- License Information
-
More Information
Article History
Received: 20 December 2023
Accepted: 30 June 2025
First Online: 25 August 2025
Competing interests
: S.C. is a (co)founder of EvolveImmune Therapeutics, Cellinfinity Bio, MagicTime Medicine and Chen Consulting, all unrelated to this study. A patent application related to this study has been filed by Yale University. The patent titled ‘Compositions and Methods for Enhancement of mRNA Vaccine Performance and Vaccination Against Mpox’ (PCT International Appl. No. PCT/US2023/081090) covers the related biotechnology. The other authors declare no competing interests.
